A detailed history of Sawtooth Solutions, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 24,398 shares of ESPR stock, worth $61,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,398
Previous 30,502 20.01%
Holding current value
$61,482
Previous $29,000 148.28%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

SELL
$0.73 - $3.08 $4,455 - $18,800
-6,104 Reduced 20.01%
24,398 $72,000
Q3 2023

Oct 19, 2023

BUY
$0.96 - $1.79 $29,281 - $54,598
30,502 New
30,502 $29,000
Q1 2023

Apr 27, 2023

BUY
$1.46 - $7.3 $16,194 - $80,971
11,092 New
11,092 $17,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $168M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.